Investigating kidney transplant outcomes from living and deceased donors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to analyze the long-term kidney transplant function outcomes based on the type of donor, either living or deceased. It involves the systematic collection of clinical data from kidney transplant recipients treated at a single center, starting from January 1, 2017, and continuing for nine years. Participants will be treated according to standard clinical practices without any additional study-specific interventions. The study will gather information during the patients' routine care to assess the impact of donor type on transplant success.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years.
* Kidney transplant recipient from any donor.
* Acquisition of Informed Consent to study participation and data processing.

Exclusion Criteria:

\-

Where it's running

• IRCCS Sant'Orsola University Hospital - Nephrology, Dialysis and Transplant Unit
  Bologna, Bo, Italy Recruiting

Study contacts

• Principal investigator: Giorgia Comai, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Giorgia Comai, MD
• Email: giorgia.comai@aosp.bo.it
• Phone: +390512144840

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preemptive genetic testing to guide tacrolimus treatment for kidney transplant patients

  This study will test whether doing a genetic test before transplant to guide tacrolimus dosing helps people on the kidney transplant waiting list stay safer and use health resources more efficiently.

  Recruiting Phase 4 Instituto de Investigación Hospital Universitario La Paz · Madrid, Madrid · NCT06701825

• Evaluating the Shingrix vaccine in kidney transplant recipients

  This study tests how well the Shingrix vaccine works and its safety for people waiting for a kidney transplant.

  Recruiting at 4 sites Phase 3 University of Colorado, Denver · Aurora, Colorado and 3 other locations · NCT04128189

• Treating blood vessel problems after a kidney transplant

  This effort will try catheter-based angioplasty and advanced imaging to see if they help kidney transplant recipients with graft dysfunction or stubborn high blood pressure from possible transplant blood‑vessel problems.

  Recruiting at 3 sites University of Aarhus · Aarhus and 2 other locations · NCT07531966

• RSV vaccine safety and immune response in lung transplant patients vs. healthy adults

  This study tests how well the RSV vaccine works and how safe it is in people who have had a lung transplant compared with healthy adults.

  Recruiting Phase 4 Seoul National University Hospital · Seoul, Jongno-Gu · NCT07895394

• Letermovir plus standard antiviral to clear CMV in lung transplant recipients

  This will test whether adding letermovir to usual antiviral treatment helps clear CMV in lung transplant recipients with active infection by week 3.

  Recruiting Phase 4 University Health Network, Toronto · Toronto, Ontario · NCT07235683

• UV-treated, antiviral-protected lungs from Hepatitis B–positive donors for transplant

  This will try using lungs from hepatitis B–positive donors that are treated with UV light during ex vivo lung perfusion plus post-transplant antiviral medicines to see if they can be safely transplanted into HBV-negative lung transplant candidates.

  Recruiting Phase 4 University Health Network, Toronto · Toronto, Ontario · NCT07189377

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.